Literature DB >> 8524793

Isolation of virus-neutralizing RNAs from a large pool of random sequences.

W Pan1, R C Craven, Q Qiu, C B Wilson, J W Wills, S Golovine, J F Wang.   

Abstract

RNA and ribonuclease-resistant RNA analogs that bound and neutralized Rous sarcoma virus (RSV) were isolated from a large pool of random sequences by multiple cycles of in vitro selection using infectious viral particles. The selected RNA pool of RSV-binding sequences at a concentration of 0.16 microM completely neutralized the virus. Of 19 sequences cloned from the selected pool, 5 inhibited RSV infection. The selected RNA and RNA analogs were shown to neutralize RSV by interacting with the virus, rather than by adversely affecting the host cells. The selection of the anti-RSV RNA and RNA analogs by intact virions immediately suggests the potential application of this approach to develop RNA and RNA analogs as inhibitors of other viruses such as human immunodeficiency virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524793      PMCID: PMC40431          DOI: 10.1073/pnas.92.25.11509

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  In vitro selection of RNAs that undergo autolytic cleavage with Pb2+.

Authors:  T Pan; O C Uhlenbeck
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

2.  SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis.

Authors:  D Irvine; C Tuerk; L Gold
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

Review 3.  Exploring molecular diversity with combinatorial shape libraries.

Authors:  D J Kenan; D E Tsai; J D Keene
Journal:  Trends Biochem Sci       Date:  1994-02       Impact factor: 13.807

Review 4.  Neutralization of animal viruses.

Authors:  N J Dimmock
Journal:  Curr Top Microbiol Immunol       Date:  1993       Impact factor: 4.291

5.  Expanding the scope of RNA catalysis.

Authors:  J R Prudent; T Uno; P G Schultz
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

Review 6.  Antiviral drugs: present status and future prospects.

Authors:  I H van der Sijs; E H Wiltink
Journal:  Int J Biochem       Date:  1994-05

Review 7.  Present status and future prospects for HIV therapies.

Authors:  M I Johnston; D F Hoth
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

8.  Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein.

Authors:  R C Craven; A E Leure-duPree; C R Erdie; C B Wilson; J W Wills
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.

Authors:  S L Orloff; M S Kennedy; A A Belperron; P J Maddon; J S McDougal
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes.

Authors:  W A Pieken; D B Olsen; F Benseler; H Aurup; F Eckstein
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

View more
  26 in total

1.  A selection system for identifying accessible sites in target RNAs.

Authors:  W H Pan; H F Devlin; C Kelley; H C Isom; G A Clawson
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

2.  Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers.

Authors:  Mihaela Lorger; Markus Engstler; Matthias Homann; H Ulrich Göringer
Journal:  Eukaryot Cell       Date:  2003-02

3.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

Review 4.  Colorimetric biosensors based on DNAzyme-assembled gold nanoparticles.

Authors:  Juewen Liu; Yi Lu
Journal:  J Fluoresc       Date:  2004-07       Impact factor: 2.217

5.  High affinity ligands from in vitro selection: complex targets.

Authors:  K N Morris; K B Jensen; C M Julin; M Weil; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  Bioactive and nuclease-resistant L-DNA ligand of vasopressin.

Authors:  K P Williams; X H Liu; T N Schumacher; H Y Lin; D A Ausiello; P S Kim; D P Bartel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 7.  Beyond DNA and RNA: The Expanding Toolbox of Synthetic Genetics.

Authors:  Alexander I Taylor; Gillian Houlihan; Philipp Holliger
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-06-03       Impact factor: 10.005

8.  A primer-free method that selects high-affinity single-stranded DNA aptamers using thermostable RNA ligase.

Authors:  Yi-Tak Lai; Jeffrey J DeStefano
Journal:  Anal Biochem       Date:  2011-03-21       Impact factor: 3.365

9.  In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection.

Authors:  J Wang; H Jiang; F Liu
Journal:  RNA       Date:  2000-04       Impact factor: 4.942

Review 10.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.